Riskpilot← Back to searchSign inGet full accessMedunga OY
OYDissolvedY-tunnus 2744349-3Puikuojantie 21Medical specialists activities · NACE 8622Est. 2016— employees
Revenue 2025
EUR 248K
+13% vs 2024
EBITDA margin
71.8%
+25% vs 2024
Equity ratio
53.7%
Financial strength
Net profit 2025
EUR 123K
+15% vs 2024
| Revenue | EUR 248K | +13% |
| EBITDA | EUR 178K | +25% |
| Net profit | EUR 123K | +15% |
| Total assets | EUR 1,3M | +32% |
| Equity | EUR 695K | +12% |
| Employees | — | — |
Legal name
Medunga OY
Y-tunnus number
2744349-3
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
9. helmikuuta 2016
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Yhtiö tuottaa lääkäripalveluita. Yhtiö voi tuottaa tai vuokrata sairaanhoitaja-, terveydenhoitaja-, kätilö- tai muita terveyspalveluita. Yhtiö voi ostaa, myydä tai vuokrata asuntoja, kiinteistöjä, asunto-osakkeita, mökkejä ja pörssiosakkeita sekä harjoittaa arvopaperikauppaa ja muuta sijoitustoimintaa.
Address
Puikuojantie 21
Phone
+358407068092
Email
sakari.unga@live.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 204 | 238 | 277 | 219 | 248 |
| Staff expenses | −33 | −33 | −23 | −23 | −3 |
| EBITDA | 128 | 100 | 160 | 143 | 178 |
| Depreciation & amort. | — | — | −0 | −0 | −0 |
| EBIT | 128 | 100 | 160 | 143 | 178 |
| Net financials | −1 | −1 | −3 | −11 | −22 |
| Profit before tax | 127 | 99 | 157 | 132 | 156 |
| Tax | 26 | 20 | 31 | 25 | 34 |
| Net profit | 101 | 79 | 126 | 106 | 123 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 494 | 521 | 77 390 | 979 | 1 293 |
| Equity | 428 | 473 | 56 051 | 622 | 695 |
| Long-term debt | — | 1 | 197 | 2 | 3 |
| Short-term debt | 66 | 48 | 21 142 | 355 | 595 |
| Total debt | 66 | 49 | 21 339 | 357 | 598 |
EBITDA margin
71.8%
This company
15.8%
Market median
+354% vs market
20212025
Equity ratio
53.7%
This company
38.2%
Market median
+41% vs market
20212025
Return on equity
17.7%
This company
18.4%
Market median
+4% vs market
20212025
Net profit margin
49.5%
This company
8.1%
Market median
+511% vs market
20212025
Asset turnover
0.19×
This company
1.12×
Market median
-83% vs market
20212025
Debt / equity
0.86×
This company
0.62×
Market median
+39% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TS Deputy Member | Deputy Member | 2016 |
| Former (1) | ||
JP Audit | Audit | 2020 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2016 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medunga OY also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Teija Susanna Unga | Deputy Member | 0 companies |
| Juha Petteri Väärälä | Audit | 0 companies |
| Alpo Sakari Unga | Board of Directors | 0 companies |